0001437749-24-003792.txt : 20240212 0001437749-24-003792.hdr.sgml : 20240212 20240212174315 ACCESSION NUMBER: 0001437749-24-003792 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220325 FILED AS OF DATE: 20240212 DATE AS OF CHANGE: 20240212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kim Dong CENTRAL INDEX KEY: 0001920163 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 24621606 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA, LTD. STREET 2: 400 ALEXANDER PARK DRIVE, 4TH FLOOR CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4/A 1 rdgdoc.xml FORM 4/A X0508 4/A 2022-03-25 2022-03-29 0001668243 UroGen Pharma Ltd. URGN 0001920163 Kim Dong 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540 1 Chief Financial Officer 0 Stock Option (right to buy) 8.61 2022-03-25 4 A 0 20000 0 A 2032-03-25 Ordinary Shares 20000 20000 D One third of the shares underlying the stock option will vest on each of March 25, 2023, March 25, 2024 and March 25, 2025. This amendment corrects and restates the number of derivative securities acquired reported in the original Form 4 filed on March 29, 2022. This amendment corrects and restates the expiration date reported in the original Form 4 filed on March 29, 2022. This amendment corrects and restates the amount of securities underlying derivative security reported in the original Form 4 filed on March 29, 2022. This amendment corrects and restates the number of derivative securities beneficially owned following reported transaction reported in the original Form 4 filed on March 29, 2022. /s/ Jason D. Smith, Attorney-in-Fact 2024-02-12